GLP-1 receptor agonist market have captured the attention of both large and small pharmaceutical companies, for more than a decade. However, after a decade-long dribble of GLP-1 drugs and the recent approval of obesity drugs, the domain has gained significant attention. Currently, more than 10 GLP-1 receptor agonists are commercially available, while various molecules are